Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Siegbert Rieg

10PUBLICATIONS
72CO-AUTHORS
Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Medical bacteriologyEpidemiological modellingDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|May 25, 2026
Health-Related Quality of Life of Patients With Infective Endocarditis-A Cross-Sectional Study Based on Data From the DERIVE Cohort.

|Nov 10, 2025
[Controversies and challenges in the management of infective endocarditis - Critical update and comments on new guidelines - Position paper of the German Society for Infectious Diseases].

Siegbert Rieg, Winfried V Kern, Rika Draenert

|Nov 25, 2024
Gram-negative bloodstream infections in six German university hospitals, 2016-2020: clinical and microbiological features.

Alexander Mischnik, Hannah Baltus, Sarah V Walker

|May 14, 2023
Concurrent analysis of hospital stay durations and mortality of emerging severe acute respiratory coronavirus virus 2 (SARS-CoV-2) variants using real-time electronic health record data at a large German university hospital.

Derek Y Hazard, Marlon Grodd, Adeline Makoudjou

|Nov 09, 2022
Long-term follow-up after introduction of a systematic sexually transmitted infection screening program for men having sex with men living with HIV in a primary care setting: uptake, STI incidence, and risk factors for infection and reinfection.

Philipp J G Mathé, Susanne Usadel, Siegbert Rieg

|Jul 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.

Andreas Greinacher, Kathleen Selleng, Julia Mayerle

Pageof 2

Frequent Collaborators

2 joint publications

Winfried V Kern

2 joint publications

Philipp Mathé

1 joint publications

Jeffrey G Klann

1 joint publications

Hossein Estiri

1 joint publications

Griffin M Weber

1 joint publications

Bertrand Moal

1 joint publications

Paul Avillach

1 joint publications

Chuan Hong

1 joint publications

Carolyn Weber

1 joint publications

Brett K Beaulieu-Jones

Frequent Collaborators

2 joint publications

Winfried V Kern

2 joint publications

Philipp Mathé

1 joint publications

Jeffrey G Klann

1 joint publications

Hossein Estiri